MedPath

Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals.

Not Applicable
Completed
Conditions
Telomere Shortening
Type 2 Diabetes Mellitus
Interventions
Behavioral: Pythagorean Self-Awareness Intervention(PSAI)
Registration Number
NCT04763525
Lead Sponsor
National and Kapodistrian University of Athens
Brief Summary

The present study explored the effects of the implementation of the Pythagorean Self Awareness Intervention (PSAI) on the dynamics of stress-related aging factors of immune cells in healthy volunteers and a cohort patients with type 2 diabetes mellitus . The primary aim was to evaluate the effectiveness of PSAI on two key biomarkers of biological age, telomere length and proteasome levels, indicative of the crosstalk between cellular oxidative status and replicative potential, with respect to metabolic, hormonal and mental status changes. Secondary aims of this study included reduction of depression, perceived stress, anxiety and the establishment of lifestyle changes to enhance the quality of everyday life, including better quality of sleep, eating behaviours and an overall healthier status.

Detailed Description

Study design This non randomized non blinded parallel trial was conducted at the Laiko Hospital of Athens, Diabetes Centre, First Department of Propaedeutic Internal Medicine of Attica, Greece, from 4.10.2018 to 26.11.2019. The study protocol was approved by the Ethics Committee of the Laiko Hospital (protocol number 5134/5-4-19) and was in accordance with the declaration of Helsinki. All participants were enlisted in the study only after being fully informed by the researcher about the aims and procedures of the research and submitting written consent.

Procedures Patients eligible for the above mentioned criteria were randomized in two groups: the group of healthy adult volunteers, and adults with type 2 diabetes who attended the outpatient diabetes clinic. This study was non-blinded, as patients and researchers were aware of the group assignment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • adequate knowledge of the Greek language
  • For participants with T2DM, a minimum of 3-month stable antidiabetic, hypolipidemic and antihypertensive treatment
  • habitants of Athens, Greece
Exclusion Criteria
  • participation in other stress management program
  • corticosteroid intake
  • diagnosis of psychiatric co-morbidity or autoimmune disease
  • change in antidiabetic, hypolipidemic, and antihypertensive treatment within the previous 3 months
  • patients with type 2 diabetes treated with insulin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention group Pythagorean Self-Awareness for healthy individualsPythagorean Self-Awareness Intervention(PSAI)N=27 healthy individuals
Intervention group Pythagorean Self-Awareness in patients with type 2 diabetesPythagorean Self-Awareness Intervention(PSAI)N=21 patients with type 2 diabetes
Primary Outcome Measures
NameTimeMethod
Determination of telomeres' length6 months

Extracted DNA from Peripheral blood mononuclear cells isolated from total blood

Determination of 20S proteasome concentration6 months

Protein extracts from Peripheral blood mononuclear cells isolated from total blood

Healthy Lifestyle and Personal Control Questionnaire6 months

Self-report questionnaire for the evaluation of a healthy lifestyle with the instrument Healthy Lifestyle and Personal Control Questionnaire that explores five dimensions of lifestyle (Organized Physical Exercise, Social Support and Mental Control, Daily Routine, Dietary Harm Avoidance, Dietary Healthy Habits).Scores range from 26 to 104 with higher scores indicating a healthier lifestyle.

Glycosylated haemoglobin6 months

total blood

Secondary Outcome Measures
NameTimeMethod
Hair cortisol concentration6 months

Hair specimens from the posterior vertex of the scalp, three cm proximal to scalp

Total Body Water6 months

Total Body Water will be reported in percent and it will be measured by the device TANITA BC418 (Tanita Cooperation, Tokyo, Japan),

Fat Free Mass6 months

Fat Free Mass will be reported in kilograms,and it will be measured by the device TANITA BC418 (Tanita Cooperation, Tokyo, Japan),

Fat Mass6 months

Fat Mass will be reported in percentage and it will be measured by the device TANITA BC418 (Tanita Cooperation, Tokyo, Japan),

Visceral fat6 months

Visceral fat will be reported in cm \^2 and it will be measured by the device TANITA BC418 (Tanita Cooperation, Tokyo, Japan)

Trunk fat6 months

Trunk fat will be reported in percentage and it will be measured by the device TANITA BC418 (Tanita Cooperation, Tokyo, Japan)

Body Mass Index6 months

Weight and height will be combined to report BMI in kg/m\^2

Depression Anxiety Stress Scale6 months

Self-referential symptoms of depression, anxiety and stress with the instrument Depression-Anxiety-Stress Scale-21 Three scores(Depression, Anxiety, Stress). Depression score ranging from 0 to 42, Anxiety score ranging from 0-42, Stress score ranging from 0-42. We expect reduction.

Perceived Stress Scale6 months

Evaluation with the self-referential instrument the Perceived Stress Scale. Score ranging from 0 to 56 with higher score indicating higher perceived stress. We expect reduction.

Self-referential quality of sleep6 months

Evaluation of sleep quality with the instrument Greek version Pittburgh Sleep Quality Index. Score ranging from 0 to 21. Score higher than 5 indicates poor sleep quality. We expect reduction.

Self-referential Internal Health Locus of Control6 months

Evaluation of internal health locus with the instrument Health Locus of Control. Score ranging from 6 to 36 with higher scores indicating higher self-control over the individual's health. We expect increase.

Self-referential External and chance Health Locus of Control6 months

Evaluation of External health locus of control and chance, with the instrument Health Locus of Control. Score ranging from 6 to 36 for each dimension. Higher score means that the individual perceives that his/her health is controlled by external factors and chance.We expect reduction.

Self-referential health locus of control Powerful others6 months

Evaluation of health locus of control for Powerful others with the instrument Health Locus of Control. Score ranging from 6 to 36.Higher score means that the individual perceives that his/her health is controlled by powerful others such as health personnel.We expect reduction.

Evaluation of verbal memory6 months

Assessment of verbal memory with the cognitive test California Verbal Learning test. Score ranging from 0 to 90 with higher score indicating better verbal memory. We expect increase.

Evaluation of visuospatial memory6 months

Assessment of visuospatial memory with the cognitive test Brief Visuospatial Memory test-Revised. Score ranging from 0 to 36 with higher score indicating better visuospatial memory.We expect increase.

Evaluation of speed processing information6 months

Assessment of speed processing of information with the cognitive test Symbol Digits Modality test. Score ranging from 0 to 95 with higher score indicating higher speed processing of information.We expect increase.

Fatigue6 months

Assessment of physical, mental and brain fatigue with a visual analogue scale with minimum as 0 indicating no fatigue at all and maximum 10 indicating high degree of fatigue. We expect reduction.

Perimeter of the waist6 months

Perimeter will be reported in centimeters

Perimeter of the neck6 months

Perimeter will be reported in centimeters

Perimeter of the hips6 months

Perimeter will be reported in centimeters

Extracellular water6 months

Extracellular water will be reported in percentage and with be assessed by a device of bioelectrical impedance technology by BIOTEKNA©, Biomedical Technologies, Venice, Italy

Intracellular water6 months

Intracellular water will be reported in percentage and it will be measured by a device of bioelectrical impedance technology by BIOTEKNA©, Biomedical Technologies, Venice, Italy

Trial Locations

Locations (1)

General University Laiko Hospital

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath